… -CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four … -
P McLaughlin, AJ Grillo-Lopez, BK Link, R Levy, MS … - Journal of Clinical Oncology, 1998 - jco.ascopubs.org
... relapsed indolent lymphoma: half of patients respond to a ... Tiuxetan Therapy Is Safe
in Patients with Prior ... Strategies for Chronic Lymphocytic Leukemia J. Clin. ...

… in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the … -
A Reiter, M Schrappe, WD Ludwig, W Hiddemann, S … - Blood, 1994 - ncbi.nlm.nih.gov
... study group for childhood acute lymphoblastic leukemia (ALL), treatment ... BFM 83, the
in vivo response to initial ... MTX) identified 10% of the patients as having a ...

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients -
HJ KOLB, A SCHATTENBERG, JM GOLDMAN, B HERTENSTEIN … - Blood, 1995 - cat.inist.fr
... In contrast, ALL did not respond to adoptive immunotherapy with donor lymphocyte
transfusions. ... Seventeen patients died without leukemia, 14 patients ...

… and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis … -
SO'Brien, H Kantarjian, M Beran, T Smith, C Koller … - Blood, 1993 - ncbi.nlm.nih.gov
... and prednisone therapy in 264 patients with chronic lymphocytic leukemia with
multivariate analysis-derived prognostic model for response to treatment. ...

… Generated From Blood Precursors of Chronic Myelogenous Leukemia Patients Carry the Philadelphia … -
B Eibl, S Ebner, C Duba, G B?ck, N Romani, M Erdel … - GENES, CHROMOSOMES & CANCER, 1997 - doi.wiley.com
... pable of inducing a cytotoxic response have been ... induce stable remissions in CML
patients relapsing after ... serve as an MHC-restricted leukemia-specific antigen ...

[PDF] … and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a … -
M Talpaz, RT Silver, BJ Druker, JM Goldman, C … - Blood, 2002 - cmlsupport.com
... 4 thrombocytopenia considered to be unrelated to leukemia. ... response was calculated
for all respond- ers as ... at last examination date for patients with ongoing ...
-

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha …
A Hochhaus, F Lin, A Reiter, H Skladny, PJ Mason, … - Blood, 1996 - ncbi.nlm.nih.gov
... degree in patients with chronic myelogenous leukemia (CML). ... Twenty-one patients were
studied at diagnosis with IFN ... 24 had a complete cytogenetic response, 21 a ...

… of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia … -
S Branford, Z Rudzki, S Walsh, A Grigg, C Arthur, … - Blood, 2002 - bloodjournal.hematologylibrary.org
... CML) or Ph-positive acute lymphoblastic leukemia (Ph + ALL ... ATP-binding region of
BCR/ABL in resistant patients. ... Certain mutations may respond to higher doses of ...

Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received … -
KR Rai, CE Freter, RJ Mercier, MR Cooper, BS … - Journal of Clinical Oncology, 2002 - jcojournal.org
... B-cell CLL and one had T-cell prolymphocytic leukemia. ... Eleven patients entered the
study with at least one ... shown in Table 3, in the responding subpopulation (n ...

… of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, … -
C Roche-Lestienne, V Soenen-Cornu, N Grardel- … - Blood, 2002 - bloodjournal.hematologylibrary.org
... after initial response to STI571 is observed in a significant proportion of patients
in advanced CML stage or in Ph-positive acute lymphoid leukemia 11 and has ...